PSDN News and Press, AdvisorShares Poseidon Dynamic Cannabis ETF From 06/13/22

Julian Lin returns to discuss two of his favorite cannabis plays - a REIT and an MSO. Cannabis investing philosophy (valuations should drive capital allocations). Net leases, cap rates and how legislation may affect bullish thesis. Smart acquisitions, management compensation, ...

Julian Lin returns to discuss two of his favorite cannabis plays - a REIT and an MSO. Cannabis investing philosophy (valuations should drive capital allocations). Net leases, cap rates and how legislation may affect bullish thesis. Smart acquisitions, management compensation, ...

Capital is disappearing in the cannabis industry. Mike Regan and Colin Ferrian return to discuss what investors need to understand about valuations (it's not just like tech). Grading California's main players, consumption patterns, price erosion. EBIDA over EBITDA. For a real ...

With Ascend Wellness - and perhaps other MSOs - set to sue the US government, we think it's a good time to hear directly from cannabis executives to get their thoughts on the industry. We hear from TerrAscend's Jason Wild, Ascend Wellness' Abner Kurtin, MariMed's Bob Fireman and Weedm...

Capital is disappearing in the cannabis industry. Mike Regan and Colin Ferrian return and we discuss what investors need to understand about valuations (it's not just like tech). Grading California's main players, consumption patterns, price erosion. EBIDA over EBITDA. For a r...

Dr. Robin Goldstein and Professor Daniel Sumner wrote Can Legal Weed Win?: The Blunt Realities of Cannabis Economics. Competition between legal and illicit market. The difference in states' timelines. What types of policies will help legal weed win, learning from other commodity m...

Julian Lin catches us up on recent earnings volatility, valuations and how investors should be looking at the cannabis industry. Why he's a big fan of Verano but not a fan of the Cresco/Columbia Care merger. IIPR, NewLake Capital and why cannabis REITs are highly compelling. ...

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings in the cannabis space and why disappointment is overblown. Favoring quality, underappreciated names due to favorable fundamentals and growth opportunities. The interesting way institutional capital is ...

Nick Gastevich, one of our favorite commenters on Seeking Alpha, returns to the show to catch us up on the state of cannabis investing. Wave of new states legalizing cannabis now especially important in the face of long federal delays. Liking GTI but it's historically had slightly...

Tim Seymour returns to talk cannabis investing within current market conditions. Interconnectivity between asset classes in the time of war and geopolitical volatility. Legislative process, wholesale prices, compression and recent cannabis earnings. Cannabis IPOs, ETFs and loo...